Nova's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 63.39.
Nova's Days Inventory for the
three
months ended in Mar. 2026 was 164.96.
Nova's Days Payable for the
three
months ended in Mar. 2026 was 46.02.
Therefore, Nova's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 182.33.
Nova (FRA:NMR) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Nova Cash Conversion Cycle Related Terms
Nova Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Nova's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:NMR vs ONTO, AMKR, FORM: Cash Conversion Cycle Comparison
For the Semiconductor Equipment & Materials subindustry, Nova's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Cash Conversion Cycle vs Semiconductors Industry
For the Semiconductors industry and Technology sector, Nova's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Nova's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Nova's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nova (FRA:NMR) has a Cash Conversion Cycle of 182.33 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Nova and its competitors.
Is Nova's Cash Conversion Cycle too high?
Nova's current Cash Conversion Cycle is 182.33. The Semiconductors industry median Cash Conversion Cycle is 116.16. Nova's value of 182.33 is 57% above this industry median. Overall, Nova has a GF Score™ of 94/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova's Cash Conversion Cycle compare to ONTO and AMKR?
Nova's Cash Conversion Cycle of 182.33 can be compared against companies in the Semiconductors industry. The industry median Cash Conversion Cycle is 116.16. Nova's value of 182.33 is 57% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Semiconductors company?
The median Cash Conversion Cycle among Semiconductors companies is 116.16, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova's current Cash Conversion Cycle of 182.33 is 57% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Nova and its competitors. For the Semiconductors industry, the median Cash Conversion Cycle is 116.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova's current Cash Conversion Cycle is 182.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova stock overvalued right now?
Based on GuruFocus' analysis, Nova (FRA:NMR) is currently considered Significantly Overvalued. The stock's GF Value™ is €274.86, compared to a current price of €414.90 — trading 50.9% above its estimated fair value. The current Cash Conversion Cycle is 182.33 and 57% above the Semiconductors industry median of 116.16. Nova's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Nova (FRA:NMR), the current Cash Conversion Cycle is 182.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova (FRA:NMR) Overvalued in 2026?
Based on GuruFocus' analysis, Nova stock appears to be overvalued.
The current stock price of €414.90 is trading 50.9% above its estimated GF Value™ of €274.86.
GuruFocus considers Nova to be Significantly Overvalued.
Key valuation signals for FRA:NMR:
Cash Conversion Cycle: 182.33
GF Value™: €274.86 vs. price of €414.90 (50.9% above fair value)
Industry Position: 57% above the Semiconductors median
No single metric tells the full story. See the FRA:NMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
94GF Score
Get the complete analysis for FRA:NMR
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NMR has been successfully added to your 
